Company news

Solana Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

December 29, 2022

Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

November 13, 2022

Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program

November 8, 2022

Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

November 7, 2022

Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

November 2, 2022

Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022

October 31, 2022

Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait

October 12, 2022

Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference

September 28, 2022

Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September

September 5, 2022

Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results

August 14, 2022

Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

August 9, 2022

Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering

August 4, 2022

Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™

July 11, 2022

Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting

June 5, 2022

Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®

May 31, 2022

Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference

May 30, 2022

Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program

May 16, 2022

Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®

May 11, 2022

Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022

May 2, 2022

Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®

April 26, 2022

Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability

April 25, 2022

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

March 13, 2022

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2022

Helius Medical Technologies, Inc. Provides Corporate Update

January 25, 2022

Helius Medical Technologies, Inc. Partners with the Medical University of South Carolina in Pilot Trial on Stroke

December 16, 2021

Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®

December 13, 2021

Helius Medical Technologies, Inc.’s Dr. Antonella Favit-Van Pelt to Present at 4th International Brain Stimulation Conference on December 9

December 5, 2021

Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

November 14, 2021

Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

November 11, 2021

Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results

November 9, 2021

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock

November 9, 2021

Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock

November 8, 2021

Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site

November 7, 2021

Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia

November 3, 2021

Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021

October 31, 2021

Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference

October 11, 2021

Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference

September 21, 2021

Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

September 13, 2021

Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 6, 2021

Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

August 24, 2021

Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

August 16, 2021

Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

August 11, 2021

Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

August 10, 2021

Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

July 11, 2021

Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

July 7, 2021

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

July 6, 2021

Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

June 29, 2021

Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer

June 14, 2021

Helius Medical Technologies, Inc. to Participate in Noble Capital Markets’ Virtual Road Show Series

June 7, 2021

Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

June 1, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 15 calls. Every call is listed under its year.

Decks

The 5 newest of 17 decks. Every deck is listed under its year.